Sildenafil Acts as Potentiator and Corrector of CFTR but Might be not Suitable for the Treatment of CF Lung Disease

Publisher： Karger

E-ISSN： 1421-9778|29|5-6|775-790

ISSN： 1015-8987

Source： Cellular Physiology and Biochemistry, Vol.29, Iss.5-6, 2012-05, pp. : 775-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NETs and CF Lung Disease: Current Status and Future Prospects

By Gray Robert D.   McCullagh Brian N.   McCray Paul B.  

Antibiotics, Vol. 4, Iss. 1, 2015-01 ,pp. : 62-75

MDPI

Access to resources Recommend Favorite

Immunochemical Analysis of Mutant CFTR in Lung Explants

By  

Cellular Physiology and Biochemistry, Vol. 30, Iss. 3, 2012-07 ,pp. : 587-595

Karger

Access to resources Recommend Favorite

Deletion of CFTR Translation Start Site Reveals Functional Isoforms of the Protein in CF Patients

By  

Cellular Physiology and Biochemistry, Vol. 24, Iss. 5-6, 2009-11 ,pp. : 335-346

Karger

Access to resources Recommend Favorite

Cl Transport in Complemented CF Bronchial Epithelial Cells Correlates with CFTR mRNA Expression Levels

By  

Cellular Physiology and Biochemistry, Vol. 22, Iss. 1-4, 2008-07 ,pp. : 057-068

Karger

Access to resources Recommend Favorite

Altered Biogenesis of ΔF508-CFTR Following Treatment with Doxorubicin

By  

Cellular Physiology and Biochemistry, Vol. 20, Iss. 5, 2008-04 ,pp. : 465-472

Karger

Access to resources Recommend Favorite